Josh Johnston, OD, FAAO

NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.

NEW ORLEANS — Twice-daily Cequa improved symptoms of dry eye disease and decreased corneal staining in patients who were still symptomatic or exhibiting signs of disease on current therapy, according to a poster presented at Academy ’23.

Some eye care specialists may believe they do not have time have time to deal with ocular surface disease — that tackling dry eye disease is too time-consuming, complicated and confusing, potentially making them inefficient with patients.

Undesirable subjective optical patterns known as dysphotopsias are one of the most common complaints following cataract surgery.

With a new pharmaceutical treatment option, my conversations with presbyopic patients have gotten a lot more exciting.

NEW ORLEANS –The new Tyrvaya nasal spray helps the body stimulate natural tears and “work like it should,” Josh Johnston, OD, said here at SECO.

A pharmaceutical approach to presbyopia has clear advantages, will likely be used in combination with other approaches and may serve to drive surgical procedures.

Visual outcomes after cataract surgery depend on accurate planning.

If we resisted telemedicine in the past, COVID-19 changed that. It’s a change for the better.

Most patients know about cataracts, but they might not fully understand what they are.